The Role of the De Ritis Ratio in ICU Mortality Among Critically Ill Patients with COVID-19
Cukurova Anestezi ve Cerrahi Bilimler Dergisi · 30.06.2026 · 9 (2) · 427-434
DOI: 10.36516/jocass.1903636 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cukurova Anestezi ve Cerrahi Bilimler Dergisi, online erschienen am 30.06.2026. Verfasst von Hüseyin Özkök und 7 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
AbstractObjective: The De Ritis ratio (aspartate aminotransferase/alanine aminotransferase) has emerged as a prognostic biomarker in critical illness. This study aimed to evaluate the independent prognostic value of the De Ritis ratio for ICU mortality in critically ill patients with COVID-19.
Methods
This retrospective observational cohort study was conducted at a single tertiary center. Medical records of 642 adult patients with RT-PCR–confirmed COVID-19 admitted to the Internal Medicine ICU between January and December 2021 were reviewed. Demographic data, comorbidities, laboratory parameters, severity scores (APACHE II and SOFA), and organ support requirements were recorded at ICU admission. Patients were stratified into survivor and non-survivor subgroups. Independent predictors of ICU mortality were identified through two multivariable logistic regression models. Discriminative performance was assessed by receiver operating characteristic curve analysis.
Results
ICU mortality was recorded in 341 patients (53.1%). Non-survivors were significantly older and had markedly elevated inflammatory biomarkers, D-dimer, urea, and De Ritis ratio values. Although absolute AST and ALT concentrations did not differ significantly between groups, the De Ritis ratio independently predicted ICU mortality in both models (Model A: OR 1.27, 95% CI 1.06–1.51, p = 0.009; Model B: OR 1.26, 95% CI 1.05–1.50, p = 0.013). Combining the De Ritis ratio with severity scores improved discrimination (AUC up to 0.661).
Conclusion
The De Ritis ratio at ICU admission independently predicted mortality in critically ill COVID-19 patients and provided prognostic information beyond established severity scores. Its derivation from routine laboratory data supports its role as a cost-neutral supplementary stratification tool.
Zitieren
APA
Özkök, H., Şenocak, Ş., Zengin, Ö. A., Genç, A. C., Çekiç, D., Durmaz, Y., Genç, A. B., & Yaylacı, S. (2026). The Role of the De Ritis Ratio in ICU Mortality Among Critically Ill Patients with COVID-19. Cukurova Anestezi ve Cerrahi Bilimler Dergisi, 9(2), 427-434. https://doi.org/10.36516/jocass.1903636
Vancouver
Özkök H, Şenocak Ş, Zengin ÖA, Genç AC, Çekiç D, Durmaz Y, et al. The Role of the De Ritis Ratio in ICU Mortality Among Critically Ill Patients with COVID-19. Cukurova Anestezi ve Cerrahi Bilimler Dergisi. 2026;9(2):427-434. doi:10.36516/jocass.1903636
BibTeX
@article{zkk2026,
author = {Özkök, Hüseyin and Şenocak, Şeyma and Zengin, Özlem Aktürk and Genç, Ahmed Cihad and Çekiç, Deniz and Durmaz, Yusuf and Genç, Ahmed Bilal and Yaylacı, Selçuk},
title = {The Role of the De Ritis Ratio in ICU Mortality Among Critically Ill Patients with COVID-19},
journal = {Cukurova Anestezi ve Cerrahi Bilimler Dergisi},
year = {2026},
volume = {9},
number = {2},
pages = {427--434},
doi = {10.36516/jocass.1903636}
}
EUVIMED